32 related articles for article (PubMed ID: 10738130)
1. Implementation of Failure Mode and Effects Analysis to the specimens flow in a population-based colorectal cancer screening programme using immunochemical faecal occult blood tests: a quality improvement project in the Milan colorectal cancer screening programme.
Deandrea S; Tidone E; Bellini A; Bisanti L; Leonardo NG; Silvestri AR; Consonni D
BMJ Open Qual; 2018; 7(1):e000299. PubMed ID: 29610774
[TBL] [Abstract][Full Text] [Related]
2. Economic Evaluations Informed Exclusively by Real World Data: A Systematic Review.
Parody-Rúa E; Rubio-Valera M; Guevara-Cuellar C; Gómez-Lumbreras A; Casajuana-Closas M; Carbonell-Duacastella C; Aznar-Lou I
Int J Environ Res Public Health; 2020 Feb; 17(4):. PubMed ID: 32059593
[TBL] [Abstract][Full Text] [Related]
3. Is a fecal occult blood test a useful tool for judging whether to perform capsule endoscopy in low-dose aspirin users with negative colonoscopy and esophagogastroduodenoscopy?
Endo H; Kato T; Sakai E; Taniguchi L; Arimoto J; Kawamura H; Higurashi T; Ohkubo H; Nonaka T; Taguri M; Inamori M; Yamanaka T; Sakaguchi T; Hata Y; Nagase H; Nakajima A
J Gastroenterol; 2017 Feb; 52(2):194-202. PubMed ID: 27095444
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of colorectal tumours in asymptomatic patients with negative immunochemical faecal occult blood test results.
Wakamura K; Kudo SE; Miyachi H; Kodama K; Hayashi S; Maeda Y; Ogawa Y; Kouyama Y; Kataoka SI; Kato K; Ichimasa K; Misawa M; Mori Y; Kudo T; Hayashi T; Ishida F; Ohkoshi S
Mol Clin Oncol; 2015 Sep; 3(5):1019-1024. PubMed ID: 26623043
[TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer screening: tests, strategies, and perspectives.
Stracci F; Zorzi M; Grazzini G
Front Public Health; 2014; 2():210. PubMed ID: 25386553
[TBL] [Abstract][Full Text] [Related]
6. Fecal immunochemical test accuracy in average-risk colorectal cancer screening.
Hernandez V; Cubiella J; Gonzalez-Mao MC; Iglesias F; Rivera C; Iglesias MB; Cid L; Castro I; de Castro L; Vega P; Hermo JA; Macenlle R; Martínez-Turnes A; Martínez-Ares D; Estevez P; Cid E; Vidal MC; López-Martínez A; Hijona E; Herreros-Villanueva M; Bujanda L; Rodriguez-Prada JI;
World J Gastroenterol; 2014 Jan; 20(4):1038-47. PubMed ID: 24574776
[TBL] [Abstract][Full Text] [Related]
7. Prediction of flare-ups of ulcerative colitis using quantitative immunochemical fecal occult blood test.
Kuriyama M; Kato J; Takemoto K; Hiraoka S; Okada H; Yamamoto K
World J Gastroenterol; 2010 Mar; 16(9):1110-4. PubMed ID: 20205282
[TBL] [Abstract][Full Text] [Related]
8. Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening?
Grazzini G; Visioli CB; Zorzi M; Ciatto S; Banovich F; Bonanomi AG; Bortoli A; Castiglione G; Cazzola L; Confortini M; Mantellini P; Rubeca T; Zappa M
Br J Cancer; 2009 Jan; 100(2):259-65. PubMed ID: 19142185
[TBL] [Abstract][Full Text] [Related]
9. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.
Westwood M; Corro Ramos I; Lang S; Luyendijk M; Zaim R; Stirk L; Al M; Armstrong N; Kleijnen J
Health Technol Assess; 2017 May; 21(33):1-234. PubMed ID: 28643629
[TBL] [Abstract][Full Text] [Related]
10. Screening for colorectal cancer with immunochemical faecal occult blood tests.
Faivre J; Dancourt V; Lejeune C
Dig Liver Dis; 2012 Dec; 44(12):967-73. PubMed ID: 22898146
[TBL] [Abstract][Full Text] [Related]
11. A cost-effective analysis of the optimum number of stool specimens collected for immunochemical occult blood screening for colorectal cancer.
Nakama H; Zhang B; Fattah AS
Eur J Cancer; 2000 Mar; 36(5):647-50. PubMed ID: 10738130
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis of immunochemical occult blood screening for colorectal cancer among three fecal sampling methods.
Yamamoto M; Nakama H
Hepatogastroenterology; 2000; 47(32):396-9. PubMed ID: 10791199
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the optimum cut-off point in immunochemical occult blood testing in screening for colorectal cancer.
Nakama H; Zhang B; Zhang X
Eur J Cancer; 2001 Feb; 37(3):398-401. PubMed ID: 11239763
[TBL] [Abstract][Full Text] [Related]
14. Colonoscopic evaluation of immunochemical fecal occult blood test for detection of colorectal neoplasia.
Nakama H; Yamamoto M; Kamijo N; Li T; Wei N; Fattah AS; Zhang B
Hepatogastroenterology; 1999; 46(25):228-31. PubMed ID: 10228797
[TBL] [Abstract][Full Text] [Related]
15. Age-related cancer detection rate and costs for one cancer detected in one screening by immunochemical fecal occult blood test.
Nakama H; Zhang B; Zhang X; Fukazawa K
Dis Colon Rectum; 2001 Nov; 44(11):1696-9. PubMed ID: 11711744
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
